| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ACACB
|
acetyl-CoA carboxylase beta
|
|
ACADVL
|
acyl-CoA dehydrogenase, very long chain
|
|
ACIN1
|
apoptotic chromatin condensation inducer 1
|
|
ACTN1
|
actinin, alpha 1
|
|
ACTN4
|
actinin, alpha 4
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AFAP1L2
|
actin filament associated protein 1-like 2
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALDH1L1
|
aldehyde dehydrogenase 1 family, member L1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ANXA2
|
annexin A2
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP5
|
aquaporin 5
|
|
AR
|
androgen receptor
|
|
ARAP1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
|
|
ARAP3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
|
|
ARHGAP5
|
Rho GTPase activating protein 5
|
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta
|
|
ARHGEF1
|
Rho guanine nucleotide exchange factor (GEF) 1
|
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
|
ASIC3
|
acid sensing (proton gated) ion channel 3
|
|
ATF2
|
activating transcription factor 2
|
|
ATF4
|
activating transcription factor 4
|
|
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATN1
|
atrophin 1
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
|
|
ATP5H
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN1
|
ataxin 1
|
|
AURKA
|
aurora kinase A
|
|
AURKAIP1
|
aurora kinase A interacting protein 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L12
|
BCL2-like 12 (proline rich)
|
|
BCR
|
breakpoint cluster region
|
|
BECN1
|
beclin 1, autophagy related
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRSK2
|
BR serine/threonine kinase 2
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
CA9
|
carbonic anhydrase IX
|
|
CAD
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
|
|
CAMK1
|
calcium/calmodulin-dependent protein kinase I
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CAMK2D
|
calcium/calmodulin-dependent protein kinase II delta
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNE2
|
cyclin E2
|
|
CD19
|
CD19 molecule
|
|
CD22
|
CD22 molecule
|
|
CD28
|
CD28 molecule
|
|
CD37
|
CD37 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD84
|
CD84 molecule
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25C
|
cell division cycle 25C
|
|
CDCA5
|
cell division cycle associated 5
|
|
CDCP1
|
CUB domain containing protein 1
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK10
|
cyclin-dependent kinase 10
|
|
CDK16
|
cyclin-dependent kinase 16
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDK7
|
cyclin-dependent kinase 7
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CELF1
|
CUGBP, Elav-like family member 1
|
|
CENPA
|
centromere protein A
|
|
CEP250
|
centrosomal protein 250kDa
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHKA
|
choline kinase alpha
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CKAP2
|
cytoskeleton associated protein 2
|
|
CLDN5
|
claudin 5
|
|
CNN3
|
calponin 3, acidic
|
|
COPS6
|
COP9 signalosome subunit 6
|
|
CORO1A
|
coronin, actin binding protein, 1A
|
|
CORO1B
|
coronin, actin binding protein, 1B
|
|
COX2
|
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CREM
|
cAMP responsive element modulator
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CROCC
|
ciliary rootlet coiled-coil, rootletin
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSNK1A1
|
casein kinase 1, alpha 1
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CSRP1
|
cysteine and glycine-rich protein 1
|
|
CSRP2
|
cysteine and glycine-rich protein 2
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTTN
|
cortactin
|
|
CUEDC2
|
CUE domain containing 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYCS
|
cytochrome c, somatic
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DACT1
|
dishevelled-binding antagonist of beta-catenin 1
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAXX
|
death-domain associated protein
|
|
DBNL
|
drebrin-like
|
|
DCD
|
dermcidin
|
|
DES
|
desmin
|
|
DLG4
|
discs, large homolog 4 (Drosophila)
|
|
DLGAP1
|
discs, large (Drosophila) homolog-associated protein 1
|
|
DNM1
|
dynamin 1
|
|
DNM1L
|
dynamin 1-like
|
|
DNM2
|
dynamin 2
|
|
DOCK1
|
dedicator of cytokinesis 1
|
|
DPYSL2
|
dihydropyrimidinase-like 2
|
|
DRD3
|
dopamine receptor D3
|
|
DUPD1
|
dual specificity phosphatase and pro isomerase domain containing 1
|
|
DYNLL1
|
dynein, light chain, LC8-type 1
|
|
E2F3
|
E2F transcription factor 3
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
ECT2
|
epithelial cell transforming 2
|
|
EEF2
|
eukaryotic translation elongation factor 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF3H
|
eukaryotic translation initiation factor 3, subunit H
|
|
EIF4B
|
eukaryotic translation initiation factor 4B
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EIF6
|
eukaryotic translation initiation factor 6
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
EMD
|
emerin
|
|
EP300
|
E1A binding protein p300
|
|
EPHA2
|
EPH receptor A2
|
|
EPHA3
|
EPH receptor A3
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
EZR
|
ezrin
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FAM84A
|
family with sequence similarity 84, member A
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FAS
|
Fas cell surface death receptor
|
|
FBXO31
|
F-box protein 31
|
|
FBXO4
|
F-box protein 4
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FER
|
fer (fps/fes related) tyrosine kinase
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FHIT
|
fragile histidine triad
|
|
FLNA
|
filamin A, alpha
|
|
FLRT1
|
fibronectin leucine rich transmembrane protein 1
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
|
FOXA2
|
forkhead box A2
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FRK
|
fyn-related Src family tyrosine kinase
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
|
GABBR2
|
gamma-aminobutyric acid (GABA) B receptor, 2
|
|
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCM1
|
glial cells missing homolog 1 (Drosophila)
|
|
GCSAM
|
germinal center-associated, signaling and motility
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GMFG
|
glia maturation factor, gamma
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GOLGA3
|
golgin A3
|
|
GPSM2
|
G-protein signaling modulator 2
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GYS1
|
glycogen synthase 1 (muscle)
|
|
H2AFX
|
H2A histone family, member X
|
|
HCLS1
|
hematopoietic cell-specific Lyn substrate 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC5
|
histone deacetylase 5
|
|
HIST1H2BB
|
histone cluster 1, H2bb
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HIST2H3C
|
histone cluster 2, H3c
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGB1
|
high mobility group box 1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPC
|
heterogeneous nuclear ribonucleoprotein C (C1/C2)
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSF4
|
heat shock transcription factor 4
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB6
|
heat shock protein, alpha-crystallin-related, B6
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HTT
|
huntingtin
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL33R
|
interleukin 33 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL9R
|
interleukin 9 receptor
|
|
ING1
|
inhibitor of growth family, member 1
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INSR
|
insulin receptor
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3BP
|
integrin beta 3 binding protein (beta3-endonexin)
|
|
ITGB4
|
integrin, beta 4
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JPH2
|
junctophilin 2
|
|
JUN
|
jun proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
KAT2A
|
K(lysine) acetyltransferase 2A
|
|
KCND2
|
potassium channel, voltage gated Shal related subfamily D, member 2
|
|
KCNE3
|
potassium channel, voltage gated subfamily E regulatory beta subunit 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNT1
|
potassium channel, sodium activated subfamily T, member 1
|
|
KDR
|
kinase insert domain receptor
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KIRREL
|
kin of IRRE like (Drosophila)
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF10
|
Kruppel-like factor 10
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KMT2E
|
lysine (K)-specific methyltransferase 2E
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT18
|
keratin 18, type I
|
|
KRT8
|
keratin 8, type II
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAT
|
linker for activation of T cells
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LDHA
|
lactate dehydrogenase A
|
|
LDLRAP1
|
low density lipoprotein receptor adaptor protein 1
|
|
LEPR
|
leptin receptor
|
|
LIMA1
|
LIM domain and actin binding 1
|
|
LIMK1
|
LIM domain kinase 1
|
|
LIMK2
|
LIM domain kinase 2
|
|
LIPE
|
lipase, hormone-sensitive
|
|
LMNA
|
lamin A/C
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRC4C
|
leucine rich repeat containing 4C
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MAGEA11
|
melanoma antigen family A11
|
|
MAK
|
male germ cell-associated kinase
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP4
|
microtubule-associated protein 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
MAPK11
|
mitogen-activated protein kinase 11
|
|
MAPK12
|
mitogen-activated protein kinase 12
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MARK2
|
MAP/microtubule affinity-regulating kinase 2
|
|
MARK3
|
MAP/microtubule affinity-regulating kinase 3
|
|
MAX
|
MYC associated factor X
|
|
MBP
|
myelin basic protein
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MCTS1
|
malignant T cell amplified sequence 1
|
|
MCU
|
mitochondrial calcium uniporter
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEF2D
|
myocyte enhancer factor 2D
|
|
MEFV
|
Mediterranean fever
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN2
|
mitofusin 2
|
|
MIP
|
major intrinsic protein of lens fiber
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MSN
|
moesin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYL12B
|
myosin, light chain 12B, regulatory
|
|
MYL9
|
myosin, light chain 9, regulatory
|
|
MYOCD
|
myocardin
|
|
MYOD1
|
myogenic differentiation 1
|
|
MYOZ2
|
myozenin 2
|
|
NACA
|
nascent polypeptide-associated complex alpha subunit
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCF4
|
neutrophil cytosolic factor 4, 40kDa
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NEK6
|
NIMA-related kinase 6
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NME3
|
NME/NM23 nucleoside diphosphate kinase 3
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NREP
|
neuronal regeneration related protein
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUAK1
|
NUAK family, SNF1-like kinase, 1
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
|
NYAP2
|
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2
|
|
OCLN
|
occludin
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OXSR1
|
oxidative stress responsive 1
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PAM
|
peptidylglycine alpha-amidating monooxygenase
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARVA
|
parvin, alpha
|
|
PAX3
|
paired box 3
|
|
PBK
|
PDZ binding kinase
|
|
PCBP1
|
poly(rC) binding protein 1
|
|
PCBP2
|
poly(rC) binding protein 2
|
|
PDCD6IP
|
programmed cell death 6 interacting protein
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PDK1
|
pyruvate dehydrogenase kinase, isozyme 1
|
|
PDLIM4
|
PDZ and LIM domain 4
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PEAK1
|
pseudopodium-enriched atypical kinase 1
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PER2
|
period circadian clock 2
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
PFN1
|
profilin 1
|
|
PFN2
|
profilin 2
|
|
PGAM1
|
phosphoglycerate mutase 1 (brain)
|
|
PGR
|
progesterone receptor
|
|
PGRMC1
|
progesterone receptor membrane component 1
|
|
PHB
|
prohibitin
|
|
PHF20
|
PHD finger protein 20
|
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIK3R2
|
phosphoinositide-3-kinase, regulatory subunit 2 (beta)
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PKM
|
pyruvate kinase, muscle
|
|
PKN1
|
protein kinase N1
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLD2
|
phospholipase D2
|
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5
|
|
PLK1
|
polo-like kinase 1
|
|
PLN
|
phospholamban
|
|
PML
|
promyelocytic leukemia
|
|
PNPLA8
|
patatin-like phospholipase domain containing 8
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPM1B
|
protein phosphatase, Mg2+/Mn2+ dependent, 1B
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B
|
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP1R1C
|
protein phosphatase 1, regulatory (inhibitor) subunit 1C
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKAR2A
|
protein kinase, cAMP-dependent, regulatory, type II, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PSEN1
|
presenilin 1
|
|
PSMC5
|
proteasome (prosome, macropain) 26S subunit, ATPase, 5
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E
|
|
PTTG1IP
|
pituitary tumor-transforming 1 interacting protein
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
PXN
|
paxillin
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD17
|
RAD17 homolog (S. pombe)
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALB
|
v-ral simian leukemia viral oncogene homolog B
|
|
RALGAPA2
|
Ral GTPase activating protein, alpha subunit 2 (catalytic)
|
|
RAP1B
|
RAP1B, member of RAS oncogene family
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RCHY1
|
ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RGS10
|
regulator of G-protein signaling 10
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RMDN3
|
regulator of microtubule dynamics 3
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RPL13A
|
ribosomal protein L13a
|
|
RPLP2
|
ribosomal protein, large, P2
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RTN4
|
reticulon 4
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SDC4
|
syndecan 4
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SGK3
|
serum/glucocorticoid regulated kinase family, member 3
|
|
SH2B1
|
SH2B adaptor protein 1
|
|
SH3GL1
|
SH3-domain GRB2-like 1
|
|
SH3GLB1
|
SH3-domain GRB2-like endophilin B1
|
|
SH3PXD2A
|
SH3 and PX domains 2A
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIRT1
|
sirtuin 1
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD5
|
SMAD family member 5
|
|
SMAD9
|
SMAD family member 9
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SP1
|
Sp1 transcription factor
|
|
SPIN1
|
spindlin 1
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRI
|
sorcin
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
SSH1
|
slingshot protein phosphatase 1
|
|
SSTR2
|
somatostatin receptor 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK11
|
serine/threonine kinase 11
|
|
STK24
|
serine/threonine kinase 24
|
|
STK3
|
serine/threonine kinase 3
|
|
STK38L
|
serine/threonine kinase 38 like
|
|
STK39
|
serine threonine kinase 39
|
|
STK4
|
serine/threonine kinase 4
|
|
STMN1
|
stathmin 1
|
|
STOML2
|
stomatin (EPB72)-like 2
|
|
SYK
|
spleen tyrosine kinase
|
|
SYN1
|
synapsin I
|
|
TACC3
|
transforming, acidic coiled-coil containing protein 3
|
|
TAGLN
|
transgelin
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBK1
|
TANK-binding kinase 1
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TEAD4
|
TEA domain family member 4
|
|
TELO2
|
telomere maintenance 2
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERT
|
telomerase reverse transcriptase
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TH
|
tyrosine hydroxylase
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TJP1
|
tight junction protein 1
|
|
TLK1
|
tousled-like kinase 1
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNIK
|
TRAF2 and NCK interacting kinase
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TNS3
|
tensin 3
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP63
|
tumor protein p63
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TRADD
|
TNFRSF1A-associated via death domain
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRIP10
|
thyroid hormone receptor interactor 10
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TTI1
|
TELO2 interacting protein 1
|
|
TTN
|
titin
|
|
TUBA1C
|
tubulin, alpha 1c
|
|
TUBB
|
tubulin, beta class I
|
|
TUBB2B
|
tubulin, beta 2B class IIb
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUBB4A
|
tubulin, beta 4A class IVa
|
|
TUBB4B
|
tubulin, beta 4B class IVb
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
UBTF
|
upstream binding transcription factor, RNA polymerase I
|
|
URI1
|
URI1, prefoldin-like chaperone
|
|
USP4
|
ubiquitin specific peptidase 4 (proto-oncogene)
|
|
VAMP2
|
vesicle-associated membrane protein 2 (synaptobrevin 2)
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VIM
|
vimentin
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
WDR77
|
WD repeat domain 77
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WIPF1
|
WAS/WASL interacting protein family, member 1
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
XBP1
|
X-box binding protein 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
